From Yahoo Finance: 2025-04-14 12:22:00

ValueInvestorsClub shared a bullish thesis on Solventum Corporation (SOLV) with a target price of $146, offering a 120% upside. SOLV is a healthcare company with four operating segments and strong leadership in its brands. The spin-off from 3M is expected to improve financial performance and capital management.

With over 70 years of experience, SOLV is projected to achieve an EBIT of $2.1 billion by 2027 with a margin expansion from 22% to 24%. The CEO and CFO have a track record of operational efficiency with spin-offs, suggesting a positive outlook for SOLV. Consider AI stocks for potentially higher returns in a shorter timeframe.

Read more: Is the Spin-Off a Blessing in Disguise?